These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 26992783)

  • 1. The pros and cons of the fourth revision of thalassaemia screening programme in Iran.
    Moafi A; Vallian R; Vallian S; Rahgozar S; Torfenajad M; Moafi H
    J Med Screen; 2017 Mar; 24(1):1-5. PubMed ID: 26992783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Premarital screening for beta-thalassaemia in Southern Iran: options for improving the programme.
    Karimi M; Jamalian N; Yarmohammadi H; Askarnejad A; Afrasiabi A; Hashemi A
    J Med Screen; 2007; 14(2):62-6. PubMed ID: 17626703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Community-initiated screening programme for beta-thalassaemia trait.
    Berdoukas VA; Webster BH; Raddatz B
    Med J Aust; 1983 Aug; 2(3):129-31. PubMed ID: 6877143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A simplified screening strategy for thalassaemia and haemoglobin E in rural communities in south-east Asia.
    Fucharoen G; Sanchaisuriya K; Sae-ung N; Dangwibul S; Fucharoen S
    Bull World Health Organ; 2004 May; 82(5):364-72. PubMed ID: 15298227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of α-thalassaemia mutations on the haematological parameters of β-thalassaemia carriers.
    Saleh-Gohari N; Khademi Bami M; Nikbakht R; Karimi-Maleh H
    J Clin Pathol; 2015 Jul; 68(7):562-6. PubMed ID: 25935548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population Screening and Prevention Strategies for Thalassemias and other Hemoglobinopathies of Eastern India: Experience of 18,166 cases.
    Chatterjee T; Chakravarty A; Chakravarty S
    Hemoglobin; 2015; 39(6):384-8. PubMed ID: 26428539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Percentile curves for red cell indices of beta zero-thalassaemia heterozygotes in infancy and childhood.
    Galanello R; Lilliu F; Bertolino F; Cao A
    Eur J Pediatr; 1991 Apr; 150(6):413-5. PubMed ID: 2040350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a prenatal screening procedure for beta-thalassaemia carriers in a Chinese population based on the mean corpuscular volume (MCV).
    Ghosh A; Woo JS; Wan CW; Machenry C; Wong V; Ma HK; Chan V; Chan TK
    Prenat Diagn; 1985; 5(1):59-65. PubMed ID: 3975223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficiency of premarital screening of beta-thalassemia trait using MCH rather than MCV in the population of Fars Province, Iran.
    Karimi M; Rasekhi AR
    Haematologia (Budap); 2002; 32(2):129-33. PubMed ID: 12412732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thalassaemia in Malaysia: a strategy for prevention.
    Ainoon O; Cheong SK
    Malays J Pathol; 1994 Jun; 16(1):23-7. PubMed ID: 16329572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of beta-thalassaemia and sickle cell traits in premarital screening in Al-Qassim, Saudi Arabia.
    El-Tayeb EN; Yaqoob M; Abdur-Rahim K; Gustavson KH
    Genet Couns; 2008; 19(2):211-8. PubMed ID: 18618996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening of antenatal patients in a multiethnic community for beta thalassaemia trait.
    Bain BJ
    J Clin Pathol; 1988 May; 41(5):481-5. PubMed ID: 3384979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening immediate family members for carrier identification and counseling: a cost-effective and practical approach.
    Ansari SH; Baig N; Shamsi TS; Saif-ur-Rehman ; Ansari ZH; Behar Z; Perveen K; Erum S; Bukhari ZR; Khan MT; Akbar M
    J Pak Med Assoc; 2012 Dec; 62(12):1314-7. PubMed ID: 23866481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thalassaemia screening in pregnancy.
    Leung TN; Lau TK; Chung TKh
    Curr Opin Obstet Gynecol; 2005 Apr; 17(2):129-34. PubMed ID: 15758603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Premarital Screening of Beta Thalassemia Minor in north-east of Iran.
    Hashemizadeh H; Noori R
    Iran J Ped Hematol Oncol; 2013; 3(1):210-5. PubMed ID: 24575266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the validity of Hb A2 and mean corpuscular haemoglobin action values in antenatal screening for beta thalassaemia carriers in England.
    Daniel Y; Cartwright R; Rennie K; Streetly A; Howard J
    Br J Haematol; 2014 Aug; 166(4):607-11. PubMed ID: 24754789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Routine screening for α-thalassaemia using an immunochromatographic strip assay for haemoglobin Bart's.
    Prayalaw P; Fucharoen G; Fucharoen S
    J Med Screen; 2014 Sep; 21(3):120-5. PubMed ID: 24907301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic Blood Disorders Survey in the Sultanate of Oman.
    Al-Riyami A; Ebrahim GJ
    J Trop Pediatr; 2003 Jul; 49 Suppl 1():i1-20. PubMed ID: 12934793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Homozygous beta-thalassemia in Algeria. Study of 50 cases].
    Adjrad L; Rouabhi F; Amara A; Girot R; Labie D; Benabadji M
    Presse Med; 1985 Nov; 14(41):2089-92. PubMed ID: 2934707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-thalassaemia trait: haematological parameters.
    Yousafzai YM; Khan S; Raziq F
    J Ayub Med Coll Abbottabad; 2010; 22(4):84-6. PubMed ID: 22455269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.